Zodasiran Phase 1: Lowering Cholesterol & Triglycerides
Breakthrough Zodasiran Trial Offers New Hope for Severe Cholesterol and Triglyceride Management In a significant leap forward for cardiovascular medicine, new data reveals that zodasiran for cholesterol reduction is effectively slashing dangerous levels of blood fats in patients with genetic lipid disorders. Results from a recent Phase 1 basket trial indicate that this experimental small … Read more